it cannot yet offer open access for all publications without considerable extra expense for authors and for the Society. In the coming years, a new model, allowing broad access, control of expenses, and the maintenance of rigorous standards of quality, will likely emerge. Third, the medical literature is challenged by the vast quantities of unfiltered information that are available in the internet age. We increasingly rely on searches using the most convenient program to quickly gather needed facts, whether the best flight schedule or the life cycle of a helminth of interest. This ready access to information is one of the hallmarks of our age, and it is a huge boon to scientific communication and advancement, but it also comes with risk. How, among all the information flowing, can rigorously reviewed and high-quality research results continue to be noticed?
Our journal also has great opportunities. Although funding for tropical medicine research remains challenging, the world has clearly embraced the concept that we all need to be concerned about tropical medicine. Tropical medicine is often equated with diseases of the most impoverished, but it is now appreciated that from practical and humanistic perspectives, the wealthier nations must contribute to the control of diseases of the developing world. Thus, funding for tropical medicine research and the control of tropical diseases has increased markedly in the past decade, heralding an age in which we can expect continuous advances in our understanding of tropical diseases and our ability to control them. The AJTMH is poised to play a major part in facilitating the communication of advances in this area. A clear opportunity for the AJTMH is to broaden its scope, for example with increased emphasis on general issues of global health, perhaps better validating the last word in the title of our journal and our society. In addition, increased attention seems warranted for some important global pathogens, including human immunodeficiency virus and mycobacteria.
Finally, what do I hope for in my term as Editor-in-Chief? First, and most important, I will strive to maintain the high quality of the journal. In this regard, I am thrilled that Joe Vinetz will remain the Associate Editor and that Jim Kazura will serve as a Section Editor; these two friends will greatly simplify my transition but also allow the continuity essential to maintaining a great journal. Second, I hope that, without sacrificing quality, we can expand our scope into areas that are fully within its domain, but have been underrepresented. Third, I hope to expand the roles of perspectives and review papers to educate readers on the latest advances in tropical medicine. Interested contributors are encouraged to discuss potential submissions with me.
In summary, I am excited about the opportunity to lead the AJTMH and look forward to working with *Address correspondence to Philip J. Rosenthal, Department of Medicine, University of California, San Francisco, Box 0811, San Francisco, CA 94143. E-mail: prosenthal@medsfgh.ucsf.edu
